sábado, 17 de junio de 2023

Cost-Effectiveness Analysis of Personalized Hypertension Prevention by Sen-Te Wang 1,2ORCID,Ting-Yu Lin 3,Tony Hsiu-Hsi Chen 3ORCID,Sam Li-Sheng Chen 4,*ORCID andJean Ching-Yuan Fann 5,*

https://www.mdpi.com/2075-4426/13/6/1001

No hay comentarios:

Publicar un comentario